OTC Healthcare in Venezuela to 2014

Introduction

This databook provides key data and information on the OTC healthcare market in Venezuela. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share.

Scope

* Contains information on:analgesics,medicated skinproduct,topicalOTC,traditional,indigestion,cough&cold,plasters&Bandages,vitamins and first aid kits

*Market,category and segment level information on value with historic (2004-09) and forecast (2010-14) data

*Category level company and brand share as well as distribution share information for 2008 and 2009

*Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description

Highlights

The market for OTC healthcare in Venezuela increased at a compound annual growth rate of 7.9% between 2004 and 2009.

The analgesics category led the OTC healthcare market in Venezuela, accounting for a share of 44.8%.

Leading players in Venezuelan OTC healthcare market include GlaxoSmithKline Plc, Johnson & Johnson and Pfizer Inc.

Reasons to Purchase

*Develop business strategies by understanding the quantitative trends within the OTC healthcare market in Venezuela

*Design effective marketing and sales strategies by identifying key market categories and segments

*Identify key players within the market to plan lucrative M&A, partnerships and agreements


Report Highlights

[Fade out the market survey infos]

TABLE OF CONTENTS
Chapter 1 Executive Summary 2
Summary market level: OTC healthcare 2
Summary category level: analgesics 3
Summary category level: topical OTC medicines 4
Summary category level: cough and cold preparations 5
Summary category level: indigestion preparations 6
Summary category level: medicated skin products 7
Summary category level: first aid kits 8
Summary category level: other OTC healthcare products 9
Summary category level: plasters & bandages 10
Summary category level: traditional medicines 11
Summary category level: vitamins and minerals 12
Chapter 2 Introduction 13
What is this report about? 13
How to use this report 13
Market definition 14
Chapter 3 Market Overview 30
Value analysis (Venezuelan Bolivar Fuerte), 2004?09 30
Value analysis (Venezuelan Bolivar Fuerte), 2009?14 32
Value analysis (US dollars), 2004?09 35
Value analysis (US dollars), 2009?14 36
Company and brand share analysis 37
Distribution analysis 42
Chapter 4 Leading Company Profiles 44
GlaxoSmithKline Plc 44
Johnson & Johnson 47
Chapter 5 Category Analysis: Analgesics 49
Value analysis (Venezuelan Bolivar Fuerte), 2004?09 49
Value analysis (Venezuelan Bolivar Fuerte), 2009?14 50
Value analysis (US dollars), 2004?09 52
Value analysis (US dollars), 2009?14 53
Company and brand share analysis 54
Distribution analysis 57
Chapter 6 Category Analysis: Topical OTC Medicines 59
Value analysis (Venezuelan Bolivar Fuerte), 2004?09 59
Value analysis (Venezuelan Bolivar Fuerte), 2009?14 60
Value analysis (US dollars), 2004?09 62
Value analysis (US dollars), 2009?14 63
Company and brand share analysis 65
Distribution analysis 67
Chapter 7 Category Analysis: Cough and Cold Preparations 69
Value analysis (Venezuelan Bolivar Fuerte), 2004?09 69
Value analysis (Venezuelan Bolivar Fuerte), 2009?14 70
Value analysis (US dollars), 2004?09 72
Value analysis (US dollars), 2009?14 73
Company and brand share analysis 75
Distribution analysis 78
Chapter 8 Category Analysis: Indigestion Preparations 80
Value analysis (Venezuelan Bolivar Fuerte), 2004?09 80
Value analysis (Venezuelan Bolivar Fuerte), 2009?14 81
Value analysis (US dollars), 2004?09 83
Value analysis (US dollars), 2009?14 83
Company and brand share analysis 85
Distribution analysis 88
Chapter 9 Category Analysis: Medicated Skin Products 90
Value analysis (Venezuelan Bolivar Fuerte), 2004?09 90
Value analysis (Venezuelan Bolivar Fuerte), 2009?14 91
Value analysis (US dollars), 2004?09 93
Value analysis (US dollars), 2009?14 94
Company and brand share analysis 96
Distribution analysis 99
Chapter 10 Category Analysis: First Aid Kits 101
Value analysis (Venezuelan Bolivar Fuerte), 2004?09 101
Value analysis (Venezuelan Bolivar Fuerte), 2009?14 102
Value analysis (US dollars), 2004?09 103
Value analysis (US dollars), 2009?14 103
Company and brand share analysis 104
Distribution analysis 107
Chapter 11 Category Analysis: Other OTC Healthcare Products 109
Value analysis (Venezuelan Bolivar Fuerte), 2004?09 109
Value analysis (Venezuelan Bolivar Fuerte), 2009?14 110
Value analysis (US dollars), 2004?09 112
Value analysis (US dollars), 2009?14 113
Company and brand share analysis 115
Distribution analysis 118
Chapter 12 Category Analysis: Plasters & Bandages 120
Value analysis (Venezuelan Bolivar Fuerte), 2004?09 120
Value analysis (Venezuelan Bolivar Fuerte), 2009?14 121
Value analysis (US dollars), 2004?09 123
Value analysis (US dollars), 2009?14 124
Company and brand share analysis 126
Distribution analysis 129
Chapter 13 Category Analysis: Traditional Medicines 131
Value analysis (Venezuelan Bolivar Fuerte), 2004?09 131
Value analysis (Venezuelan Bolivar Fuerte), 2009?14 132
Value analysis (US dollars), 2004?09 133
Value analysis (US dollars), 2009?14 133
Company and brand share analysis 134
Distribution analysis 136
Chapter 14 Category Analysis: Vitamins and Minerals 138
Value analysis (Venezuelan Bolivar Fuerte), 2004?09 138
Value analysis (Venezuelan Bolivar Fuerte), 2009?14 139
Value analysis (US dollars), 2004?09 141
Value analysis (US dollars), 2009?14 141
Company and brand share analysis 143
Distribution analysis 146
Chapter 15 Country Comparison 148
Value 148
Market share 152
Chapter 16 New Product Development 153
Product launches over time 153
Recent product launches 155
Chapter 17 Macroeconomic Profile 156
Macroeconomic Indicators 156
Chapter 18 Research Methodology 161
Methodology overview 161
Secondary research 162
Market modeling 163
Creating an initial data model 163
Revising the initial data model 163
Creating a final estimate 164
Creating demographic value splits 164
Primary research 164
Data finalization 165
Ongoing research 165
Chapter 19 Appendix 166
Future readings 166
How to contact experts in your industry 166
Disclaimer 166

LIST OF FIGURES
Figure 1: OTC healthcare, Venezuela, value by category (VEFm), 2004?14 34
Figure 2: OTC healthcare, Venezuela, company share by value (%), 2008?09 39
Figure 3: OTC healthcare, Venezuela, distribution channels by value (%), 2008?09 43
Figure 4: Analgesics, Venezuela, value by segment (VEFm), 2004?14 51
Figure 5: Analgesics, Venezuela, category growth comparison, by value, 2004?14 53
Figure 6: Analgesics, Venezuela, company share by value (%), 2008?09 55
Figure 7: Analgesics, Venezuela, distribution channels by value (%), 2008?09 58
Figure 8: Topical OTC medicines, Venezuela, value by segment (VEFm), 2004?14 61
Figure 9: Topical OTC medicines, Venezuela, category growth comparison, by value, 2004?14 64
Figure 10: Topical OTC medicines, Venezuela, distribution channels by value (%), 2008?09 68
Figure 11: Cough and cold preparations, Venezuela, value by segment (VEFm), 2004?14 71
Figure 12: Cough and cold preparations, Venezuela, category growth comparison, by value, 2004?14 74
Figure 13: Cough and cold preparations, Venezuela, company share by value (%), 2008?09 76
Figure 14: Cough and cold preparations, Venezuela, distribution channels by value (%), 2008?09 79
Figure 15: Indigestion preparations, Venezuela, value by segment (VEFm), 2004?14 82
Figure 16: Indigestion preparations, Venezuela, category growth comparison, by value, 2004?14 84
Figure 17: Indigestion preparations, Venezuela, company share by value (%), 2008?09 86
Figure 18: Indigestion preparations, Venezuela, distribution channels by value (%), 2008?09 89
Figure 19: Medicated skin products, Venezuela, value by segment (VEFm), 2004?14 92
Figure 20: Medicated skin products, Venezuela, category growth comparison, by value, 2004?14 95
Figure 21: Medicated skin products, Venezuela, company share by value (%), 2008?09 97
Figure 22: Medicated skin products, Venezuela, distribution channels by value (%), 2008?09 100
Figure 23: First aid kits, Venezuela, value (VEFm), 2004?14 102
Figure 24: First aid kits, Venezuela, company share by value (%), 2008?09 105
Figure 25: First aid kits, Venezuela, distribution channels by value (%), 2008?09 108
Figure 26: Other OTC healthcare products, Venezuela, value by segment (VEFm), 2004?14 111
Figure 27: Other OTC healthcare products, Venezuela, category growth comparison, by value, 2004?14 114
Figure 28: Other OTC healthcare products, Venezuela, company share by value (%), 2008?09 116
Figure 29: Other OTC healthcare products, Venezuela, distribution channels by value (%), 2008?09 119
Figure 30: Plasters & bandages, Venezuela, value by segment (VEFm), 2004?14 122
Figure 31: Plasters & bandages, Venezuela, category growth comparison, by value, 2004?14 125
Figure 32: Plasters & bandages, Venezuela, company share by value (%), 2008?09 127
Figure 33: Plasters & bandages, Venezuela, distribution channels by value (%), 2008?09 130
Figure 34: Traditional medicines, Venezuela, value (VEFm), 2004?14 132
Figure 35: Traditional medicines, Venezuela, distribution channels by value (%), 2008?09 137
Figure 36: Vitamins and minerals, Venezuela, value by segment (VEFm), 2004?14 140
Figure 37: Vitamins and minerals, Venezuela, category growth comparison, by value, 2004?14 142
Figure 38: Vitamins and minerals, Venezuela, company share by value (%), 2008?09 144
Figure 39: Vitamins and minerals, Venezuela, distribution channels by value (%), 2008?09 147
Figure 40: Global OTC healthcare market split (value terms, 2009), top five countries 149
Figure 41: Global OTC healthcare market value, 2004Ð09, top five countries 151
Figure 42: Annual data review process 162

LIST OF TABLES
Table 1: OTC healthcare category definitions 15
Table 2: OTC healthcare distribution channels 17
Table 3: OTC healthcare, Venezuela, value by category (VEFm), 2004?09 31
Table 4: OTC healthcare, Venezuela, value forecast by category (VEFm), 2009?14 33
Table 5: OTC healthcare, Venezuela, value by category ($m), 2004?09 35
Table 6: OTC healthcare, Venezuela, value forecast by category ($m), 2009?14 36
Table 7: OTC healthcare, Venezuela, brand share by value (%), 2008?09 37
Table 8: OTC healthcare, Venezuela, value by brand (VEFm), 2008?09 38
Table 9: OTC healthcare, Venezuela, company share by value (%), 2008?09 40
Table 10: OTC healthcare, Venezuela, value by company (VEFm), 2008?09 41
Table 11: OTC healthcare, Venezuela, distribution channels by value (%), 2008?09 42
Table 12: OTC healthcare, Venezuela, value by distribution channel (VEFm), 2008?09 42
Table 13: GlaxoSmithKline Plc key facts 44
Table 14: Johnson & Johnson key facts 47
Table 15: Analgesics, Venezuela, value by segment (VEFm), 2004?09 49
Table 16: Analgesics, Venezuela, value forecast by segment (VEFm), 2009?14 50
Table 17: Analgesics, Venezuela, value by segment ($m), 2004?09 52
Table 18: Analgesics, Venezuela, value forecast by segment ($m), 2009?14 53
Table 19: Analgesics, Venezuela, brand share by value (%), 2008?09 54
Table 20: Analgesics, Venezuela, value by brand (VEFm), 2008?09 54
Table 21: Analgesics, Venezuela, company share by value (%), 2008?09 56
Table 22: Analgesics, Venezuela, value by company (VEFm), 2008?09 56
Table 23: Analgesics, Venezuela, distribution channels by value (%), 2008?09 57
Table 24: Analgesics, Venezuela, value by distribution channel (VEFm), 2008?09 57
Table 25: Topical OTC medicines, Venezuela, value by segment (VEFm), 2004?09 59
Table 26: Topical OTC medicines, Venezuela, value forecast by segment (VEFm), 2009?14 60
Table 27: Topical OTC medicines, Venezuela, value by segment ($m), 2004?09 62
Table 28: Topical OTC medicines, Venezuela, value forecast by segment ($m), 2009?14 63
Table 29: Topical OTC medicines, Venezuela, brand share by value (%), 2008?09 65
Table 30: Topical OTC medicines, Venezuela, value by brand (VEFm), 2008?09 65
Table 31: Topical OTC medicines, Venezuela, company share by value (%), 2008?09 66
Table 32: Topical OTC medicines, Venezuela, value by company (VEFm), 2008?09 66
Table 33: Topical OTC medicines, Venezuela, distribution channels by value (%), 2008?09 67
Table 34: Topical OTC medicines, Venezuela, value by distribution channel (VEFm), 2008?09 67
Table 35: Cough and cold preparations, Venezuela, value by segment (VEFm), 2004?09 69
Table 36: Cough and cold preparations, Venezuela, value forecast by segment (VEFm), 2009?14 70
Table 37: Cough and cold preparations, Venezuela, value by segment ($m), 2004?09 72
Table 38: Cough and cold preparations, Venezuela, value forecast by segment ($m), 2009?14 73
Table 39: Cough and cold preparations, Venezuela, brand share by value (%), 2008?09 75
Table 40: Cough and cold preparations, Venezuela, value by brand (VEFm), 2008?09 75
Table 41: Cough and cold preparations, Venezuela, company share by value (%), 2008?09 77
Table 42: Cough and cold preparations, Venezuela, value by company (VEFm), 2008?09 77
Table 43: Cough and cold preparations, Venezuela, distribution channels by value (%), 2008?09 78
Table 44: Cough and cold preparations, Venezuela, value by distribution channel (VEFm), 2008?09 78
Table 45: Indigestion preparations, Venezuela, value by segment (VEFm), 2004?09 80
Table 46: Indigestion preparations, Venezuela, value forecast by segment (VEFm), 2009?14 81
Table 47: Indigestion preparations, Venezuela, value by segment ($m), 2004?09 83
Table 48: Indigestion preparations, Venezuela, value forecast by segment ($m), 2009?14 83
Table 49: Indigestion preparations, Venezuela, brand share by value (%), 2008?09 85
Table 50: Indigestion preparations, Venezuela, value by brand (VEFm), 2008?09 85
Table 51: Indigestion preparations, Venezuela, company share by value (%), 2008?09 87
Table 52: Indigestion preparations, Venezuela, value by company (VEFm), 2008?09 87
Table 53: Indigestion preparations, Venezuela, distribution channels by value (%), 2008?09 88
Table 54: Indigestion preparations, Venezuela, value by distribution channel (VEFm), 2008?09 88
Table 55: Medicated skin products, Venezuela, value by segment (VEFm), 2004?09 90
Table 56: Medicated skin products, Venezuela, value forecast by segment (VEFm), 2009?14 91
Table 57: Medicated skin products, Venezuela, value by segment ($m), 2004?09 93
Table 58: Medicated skin products, Venezuela, value forecast by segment ($m), 2009?14 94
Table 59: Medicated skin products, Venezuela, brand share by value (%), 2008?09 96
Table 60: Medicated skin products, Venezuela, value by brand (VEFm), 2008?09 96
Table 61: Medicated skin products, Venezuela, company share by value (%), 2008?09 98
Table 62: Medicated skin products, Venezuela, value by company (VEFm), 2008?09 98
Table 63: Medicated skin products, Venezuela, distribution channels by value (%), 2008?09 99
Table 64: Medicated skin products, Venezuela, value by distribution channel (VEFm), 2008?09 99
Table 65: First aid kits, Venezuela, value (VEFm), 2004?09 101
Table 66: First aid kits, Venezuela, value forecast (VEFm), 2009?14 102
Table 67: First aid kits, Venezuela, value ($m), 2004?09 103
Table 68: First aid kits, Venezuela, value forecast ($m), 2009?14 103
Table 69: First aid kits, Venezuela, brand share by value (%), 2008?09 104
Table 70: First aid kits, Venezuela, value by brand (VEFm), 2008?09 104
Table 71: First aid kits, Venezuela, company share by value (%), 2008?09 106
Table 72: First aid kits, Venezuela, value by company (VEFm), 2008?09 106
Table 73: First aid kits, Venezuela, distribution channels by value (%), 2008?09 107
Table 74: First aid kits, Venezuela, value by distribution channel (VEFm), 2008?09 107
Table 75: Other OTC healthcare products, Venezuela, value by segment (VEFm), 2004?09 109
Table 76: Other OTC healthcare products, Venezuela, value forecast by segment (VEFm), 2009?14 110
Table 77: Other OTC healthcare products, Venezuela, value by segment ($m), 2004?09 112
Table 78: Other OTC healthcare products, Venezuela, value forecast by segment ($m), 2009?14 113
Table 79: Other OTC healthcare products, Venezuela, brand share by value (%), 2008?09 115
Table 80: Other OTC healthcare products, Venezuela, value by brand (VEFm), 2008?09 115
Table 81: Other OTC healthcare products, Venezuela, company share by value (%), 2008?09 117
Table 82: Other OTC healthcare products, Venezuela, value by company (VEFm), 2008?09 117
Table 83: Other OTC healthcare products, Venezuela, distribution channels by value (%), 2008?09 118
Table 84: Other OTC healthcare products, Venezuela, value by distribution channel (VEFm), 2008?09 118
Table 85: Plasters & bandages, Venezuela, value by segment (VEFm), 2004?09 120
Table 86: Plasters & bandages, Venezuela, value forecast by segment (VEFm), 2009?14 121
Table 87: Plasters & bandages, Venezuela, value by segment ($m), 2004?09 123
Table 88: Plasters & bandages, Venezuela, value forecast by segment ($m), 2009?14 124
Table 89: Plasters & bandages, Venezuela, brand share by value (%), 2008?09 126
Table 90: Plasters & bandages, Venezuela, value by brand (VEFm), 2008?09 126
Table 91: Plasters & bandages, Venezuela, company share by value (%), 2008?09 128
Table 92: Plasters & bandages, Venezuela, value by company (VEFm), 2008?09 128
Table 93: Plasters & bandages, Venezuela, distribution channels by value (%), 2008?09 129
Table 94: Plasters & bandages, Venezuela, value by distribution channel (VEFm), 2008?09 129
Table 95: Traditional medicines, Venezuela, value (VEFm), 2004?09 131
Table 96: Traditional medicines, Venezuela, value forecast (VEFm), 2009?14 132
Table 97: Traditional medicines, Venezuela, value ($m), 2004?09 133
Table 98: Traditional medicines, Venezuela, value forecast ($m), 2009?14 133
Table 99: Traditional medicines, Venezuela, brand share by value (%), 2008?09 134
Table 100: Traditional medicines, Venezuela, value by brand (VEFm), 2008?09 134
Table 101: Traditional medicines, Venezuela, company share by value (%), 2008?09 135
Table 102: Traditional medicines, Venezuela, value by company (VEFm), 2008?09 135
Table 103: Traditional medicines, Venezuela, distribution channels by value (%), 2008?09 136
Table 104: Traditional medicines, Venezuela, value by distribution channel (VEFm), 2008?09 136
Table 105: Vitamins and minerals, Venezuela, value by segment (VEFm), 2004?09 138
Table 106: Vitamins and minerals, Venezuela, value forecast by segment (VEFm), 2009?14 139
Table 107: Vitamins and minerals, Venezuela, value by segment ($m), 2004?09 141
Table 108: Vitamins and minerals, Venezuela, value forecast by segment ($m), 2009?14 141
Table 109: Vitamins and minerals, Venezuela, brand share by value (%), 2008?09 143
Table 110: Vitamins and minerals, Venezuela, value by brand (VEFm), 2008?09 143
Table 111: Vitamins and minerals, Venezuela, company share by value (%), 2008?09 145
Table 112: Vitamins and minerals, Venezuela, value by company (VEFm), 2008?09 145
Table 113: Vitamins and minerals, Venezuela, distribution channels by value (%), 2008?09 146
Table 114: Vitamins and minerals, Venezuela, value by distribution channel (VEFm), 2008?09 146
Table 115: Global OTC healthcare market value, 2009 148
Table 116: Global OTC healthcare market split (value terms ($m), 2009), top five countries 151
Table 117: Leading players, top five countries 152
Table 118: Venezuela OTC healthcare new product launches reports, by company (top five companies), 2009 153
Table 119: Venezuela OTC healthcare new product launches SKUs, by company (top five companies), 2009 153
Table 120: Venezuela OTC healthcare new product launches (reports), by flavor and fragrances, 2009 154
Table 121: Venezuela OTC healthcare new product launches (reports), by ingredients (top 10 ingredients), 2009 154
Table 122: Venezuela OTC healthcare new product launches (reports), by package tags or claims, 2009 155
Table 123: Venezuela OTC healthcare new product launches - recent five launches (2009) 155
Table 124: Venezuela population, by age group, 2004?09 (millions) 156
Table 125: Venezuela population forecast, by age group, 2009?14 (millions) 157
Table 126: Venezuela population, by gender, 2004?09 (millions) 157
Table 127: Venezuela population forecast, by gender, 2009?14 (millions) 158
Table 128: Venezuela nominal GDP, 2004?09 (VEFbn, nominal prices) 158
Table 129: Venezuela nominal GDP forecast, 2009?14 (VEFbn, nominal prices) 158
Table 130: Venezuela real GDP, 2004?09 (VEFbn, 2000 prices) 159
Table 131: Venezuela real GDP forecast, 2009?14 (VEFbn, 2000 prices) 159
Table 132: Venezuela real GDP, 2004?09 ($bn, 2000 prices) 159
Table 133: Venezuela real GDP forecast, 2009?14 ($bn, 2000 prices) 160
Table 134: Venezuela consumer price index, 2004?09 (2000=100) 160
Table 135: Venezuela consumer price index, 2009?14 (2000=100) 160



[Fade out table of contents]